TheEdgeResearch
Home / Stocks / EOFBY

Ecofibre Limited (EOFBY)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.84 ▲ +0.00%
Market Cap
$73.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.54
52-Wk Range
0.8438-1.36
CEO
Eric Wang
Country
AU
Currency
USD

Ecofibre Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.84, up 0.00% on the session, giving a market capitalisation of $73.7M. On trailing twelve-month figures it carries a trailing P/E of -0.17, a net margin of -158.5%. Its beta of 1.54 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.17
Price / Sales
0.26
Price / Book
0.18
EV / EBITDA
-0.68
Gross margin
-3.9%
Operating margin
-53.7%
Net margin
-158.5%
Return on equity
Debt / equity
0.64
Current ratio
1.80
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2022-04-14
Headquarters
Sydney, NSW, AU
About Ecofibre Limited

Ecofibre Limited, along with its associated companies, is engaged in the full spectrum of hemp product activities, encompassing cultivation, manufacturing, promotion, and distribution in both the United States and Australia. Its operations are structured into three distinct divisions: Ananda Health, Ananda Food, and Hemp Black. The company's diverse product range includes cannabidiol (CBD) items for human and pet use, topical health and beauty formulations, various hemp-derived food products, and industrial hemp textiles. Ecofibre Limited was established in 2009 and has its headquarters in Sydney, Australia.

Comparable companies

Ecofibre Limited is most often compared with the following Healthcare names:

BIOGFCKMTFEEOIFETXPFGDNSFINNPFKDEVFKIARFSYMQYTIHE
More research on EOFBY
EOFBY technical analysis EOFBY TheEdge Score Compare against peers
Open full interactive analysis & DCF →